Business ❯Pharmaceuticals

Product Development

FDA Approval Research and Development Commercialization

Boehringer Ingelheim Reports Strong 2024 Growth and Prepares for New Product Launches in 2025

FDA Approves Neffy, the First Needle-Free Epinephrine Nasal Spray for Anaphylaxis